About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Tramadol
- Procedure number
- PSUSA/00003002/202005
- Regulatory outcome
- Variation
Documents
Tramadol: List of nationally authorised medicinal products - PSUSA/00003002/202005
List of nationally authorised medicinal products
English (EN) (2.3 MB - PDF)
Tramadol: CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00003002/202005
CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation
English (EN) (199.01 KB - PDF)
български (BG) (228.07 KB - PDF)
español (ES) (214.08 KB - PDF)
čeština (CS) (282.64 KB - PDF)
dansk (DA) (178.93 KB - PDF)
Deutsch (DE) (203.88 KB - PDF)
eesti keel (ET) (196.26 KB - PDF)
ελληνικά (EL) (255.31 KB - PDF)
français (FR) (105.6 KB - PDF)
hrvatski (HR) (247.66 KB - PDF)
íslenska (IS) (213.74 KB - PDF)
italiano (IT) (220.66 KB - PDF)
latviešu valoda (LV) (246.72 KB - PDF)
lietuvių kalba (LT) (244.77 KB - PDF)
magyar (HU) (269.79 KB - PDF)
Malti (MT) (283.18 KB - PDF)
Nederlands (NL) (189.31 KB - PDF)
norsk (NO) (208.41 KB - PDF)
polski (PL) (241.34 KB - PDF)
português (PT) (183.34 KB - PDF)
română (RO) (220.02 KB - PDF)
slovenčina (SK) (248.59 KB - PDF)
slovenščina (SL) (241.04 KB - PDF)
Suomi (FI) (195.52 KB - PDF)
svenska (SV) (171.02 KB - PDF)